Alexandra Kropotova serves as Executive at SAB Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Alexandra Kropotova has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 11, 2025 involved selling 988 shares valued at $0.
Alexandra Kropotova currently holds 44,284 shares of SAB Biotherapeutics, Inc. (SABS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alexandra Kropotova has been a net neutral trader of SABS stock. They have purchased $0 and sold $0 worth of shares.
Alexandra Kropotova's most recent insider trade was on Dec 11, 2025, when they sold 988 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 14, 2023 | SABS | $0 | Award | 275,000 | $N/A | Discretionary |
| Jun 6, 2022 | SABS | $0 | Award | 300,000 | $N/A | Discretionary |